Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial


Hamuryudan V. , Mat C., Saip S. , Ozyazgan Y. , Siva A. , Yurdakul S. , ...More

ANNALS OF INTERNAL MEDICINE, vol.128, no.6, pp.443-451, 1998 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 128 Issue: 6
  • Publication Date: 1998
  • Doi Number: 10.7326/0003-4819-128-6-199803150-00004
  • Title of Journal : ANNALS OF INTERNAL MEDICINE
  • Page Numbers: pp.443-451

Abstract

Background: Recurrent oral and genital ulcers are the most frequent problem in the management of the Behcet syndrome. Uncontrolled experience suggests that thalidomide may help prevent recurrences of these ulcers.